SHANGHAI JUNSHI BIOSCIENCES CO., LTD.*


                                         1877




                2022   1   3                            H

                                   571                      XIVA




                                         45

                               2
                           1                                   22




       2021
                  (first-in-class)
BTLA   CD39   IL-21 CD112R (PVRIG)       PD-1/TGF-β   TIGIT




                                   1
    2021   10

                               Biologics License Application
                   FDA                  FDA


                                                         COVID-19
                                                    etesevimab JS016
JS026                        VV116                                15




            2022    1    6




                                 Roy Steven Herbst


*




                                     2